Accelerated Approval Bill In Senate Tracks House Draft, But With More Of A Nod To FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate measure adds a provision on breakthrough therapies and specifies that accelerated approval provisions do not alter substantial evidence standard used to approve drugs.